Dr Daniel L Platter, MD | |
10180 Se Sunnyside Rd, Kaiser Sunnyside Medical Office, Clackamas, OR 97015-9764 | |
(503) 652-2880 | |
Not Available |
Full Name | Dr Daniel L Platter |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 10180 Se Sunnyside Rd, Clackamas, Oregon |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972614865 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD23702 (Oregon) | Primary |
Entity Name | Kaiser Foundation Health Plan Of The Northwest |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Two genes, TSC1 and MTOR, warrant further investigation as biomarkers for treatment benefit with rapalogs in patients with renal cell carcinoma, indicate study results published in Clinical Cancer Research.
The Gary and Mary West Foundation today announced a $25 million commitment to enable the West Wireless Health Institute (WWHI) to amplify its aggressive recruitment of world class engineering talent and accelerate its mission on a national and global scale. The additional funding comes on the heels of a $20 million grant announced last month, and brings the total support provided by the foundation to nearly $100 million since the Institute's inception in March 2009.
Obesity and severe obesity continued to grow among adults in the United States between 2007-2008 and 2015-2016 but there were no significant overall changes among youth.
It is not unusual for babies to be born with congenital heart defects. This is because the development of the heart in the embryo is a process which is not only extremely complex, but also error-prone. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now identified a key molecule that plays a central role in regulating the function of stem cells in the heart.
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. S-kaly from the Universit- de Montr-al.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daniel L Platter, MD 10180 Se Sunnyside Rd, Kaiser Sunnyside Medical Office, Clackamas, OR 97015-9764 Ph: (503) 652-2880 | Dr Daniel L Platter, MD 10180 Se Sunnyside Rd, Kaiser Sunnyside Medical Office, Clackamas, OR 97015-9764 Ph: (503) 652-2880 |
News Archive
Two genes, TSC1 and MTOR, warrant further investigation as biomarkers for treatment benefit with rapalogs in patients with renal cell carcinoma, indicate study results published in Clinical Cancer Research.
The Gary and Mary West Foundation today announced a $25 million commitment to enable the West Wireless Health Institute (WWHI) to amplify its aggressive recruitment of world class engineering talent and accelerate its mission on a national and global scale. The additional funding comes on the heels of a $20 million grant announced last month, and brings the total support provided by the foundation to nearly $100 million since the Institute's inception in March 2009.
Obesity and severe obesity continued to grow among adults in the United States between 2007-2008 and 2015-2016 but there were no significant overall changes among youth.
It is not unusual for babies to be born with congenital heart defects. This is because the development of the heart in the embryo is a process which is not only extremely complex, but also error-prone. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now identified a key molecule that plays a central role in regulating the function of stem cells in the heart.
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. S-kaly from the Universit- de Montr-al.
› Verified 8 days ago
Megan Lea Kelly, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10180 Se Sunnyside Rd, Kaiser Sunnyside Medical Center, Clackamas, OR 97015 Phone: 503-652-2880 | |
Dr. Nicholas Markham Leonard, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880 | |
Dr. Alexander Marsh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10180 Se Sunnyside Rd, Kaiser Permanente, Clackamas, OR 97015 Phone: 503-571-8488 | |
James Edward Wood, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880 | |
Pamela Marie Johnson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880 | |
John Mullen, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880 | |
Cameron D Klug, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-2000 |